Wells Fargo & Company Immunome Inc. Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in Immunome Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 18,543 shares of IMNM stock, worth $246,992. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,543
Previous 4,214 340.03%
Holding current value
$246,992
Previous $104,000 115.38%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$11.54 - $22.11 $165,356 - $316,814
14,329 Added 340.03%
18,543 $224,000
Q1 2024

May 10, 2024
BUY
$11.01 - $27.34 $24,177 - $60,038
2,196 Added 108.82%
4,214 $104,000
Q4 2023

Feb 09, 2024
BUY
$7.3 - $10.73 $1,241 - $1,824
170 Added 9.2%
2,018 $21,000
Q3 2023

Nov 13, 2023
SELL
$6.17 - $9.16 $55 - $82
-9 Reduced 0.48%
1,848 $15,000
Q2 2023

Aug 15, 2023
BUY
$4.7 - $7.91 $14 - $23
3 Added 0.16%
1,857 $14,000
Q1 2023

May 12, 2023
BUY
$3.26 - $5.69 $3 - $5
1 Added 0.05%
1,854 $9,000
Q4 2022

Feb 13, 2023
BUY
$2.21 - $5.0 $4 - $10
2 Added 0.11%
1,853 $4,000
Q3 2022

Nov 14, 2022
SELL
$3.39 - $6.14 $3 - $6
-1 Reduced 0.05%
1,851 $8,000
Q2 2022

Aug 12, 2022
BUY
$2.24 - $5.79 $13 - $34
6 Added 0.33%
1,852 $6,000
Q1 2022

May 16, 2022
BUY
$3.88 - $13.99 $6,925 - $24,972
1,785 Added 2926.23%
1,846 $10,000
Q4 2021

Feb 14, 2022
BUY
$12.96 - $23.44 $25 - $46
2 Added 3.39%
61 $1,000
Q3 2021

Nov 15, 2021
BUY
$12.5 - $27.76 $375 - $832
30 Added 103.45%
59 $1,000
Q2 2021

Aug 16, 2021
SELL
$16.33 - $32.33 $10,369 - $20,529
-635 Reduced 95.63%
29 $1,000
Q1 2021

May 13, 2021
SELL
$9.56 - $43.24 $5,917 - $26,765
-619 Reduced 48.25%
664 $22,000
Q4 2020

Feb 09, 2021
BUY
$9.46 - $14.16 $12,137 - $18,167
1,283 New
1,283 $12,000

Others Institutions Holding IMNM

# of Institutions
118
Shares Held
43.7M
Call Options Held
67.2K
Put Options Held
65.9K
View Full List

About Immunome Inc.

IMNM Quotes by TradingView
  • Ticker IMNM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,127,400
  • Market Cap $162M
  • Description
  • Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...
More about IMNM
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email